Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | PAN domain-containing protein | 0.002 | 0.0191 | 0.0191 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0018 | 0.0135 | 0.5 |
Brugia malayi | PAN domain containing protein | 0.002 | 0.0191 | 0.0158 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0018 | 0.0135 | 0.037 |
Brugia malayi | PAN domain containing protein | 0.002 | 0.0191 | 0.0158 |
Loa Loa (eye worm) | PAN domain-containing protein | 0.002 | 0.0191 | 0.0191 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.0534 | 0.114 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0191 | 0.0191 |
Schistosoma mansoni | lamin | 0.0026 | 0.0325 | 0.0542 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0014 | 0.0033 | 0.0033 |
Toxoplasma gondii | hypothetical protein | 0.002 | 0.0191 | 0.0077 |
Schistosoma mansoni | lamin | 0.0026 | 0.0325 | 0.0542 |
Schistosoma mansoni | hypothetical protein | 0.0164 | 0.3639 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0018 | 0.0135 | 0.5 |
Brugia malayi | hypothetical protein | 0.0035 | 0.0534 | 0.0502 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0018 | 0.0135 | 0.5 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0018 | 0.0135 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0534 | 1 |
Onchocerca volvulus | 0.0026 | 0.0325 | 0.0136 | |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0018 | 0.0135 | 0.5 |
Loa Loa (eye worm) | intermediate filament protein | 0.0026 | 0.0325 | 0.0325 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0018 | 0.0135 | 0.5 |
Loa Loa (eye worm) | PAN domain-containing protein | 0.002 | 0.0191 | 0.0191 |
Schistosoma mansoni | lozenge | 0.0054 | 0.099 | 0.244 |
Toxoplasma gondii | PAN domain-containing protein | 0.002 | 0.0191 | 0.0077 |
Brugia malayi | PAN domain containing protein | 0.002 | 0.0191 | 0.0158 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0018 | 0.0135 | 0.5 |
Brugia malayi | PAN domain containing protein | 0.002 | 0.0191 | 0.0158 |
Toxoplasma gondii | PAN domain-containing protein | 0.0318 | 0.7364 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0018 | 0.0135 | 0.5 |
Echinococcus granulosus | lamin | 0.0026 | 0.0325 | 0.0892 |
Loa Loa (eye worm) | PAN domain-containing protein | 0.002 | 0.0191 | 0.0191 |
Toxoplasma gondii | microneme protein MIC4 | 0.002 | 0.0191 | 0.0077 |
Toxoplasma gondii | 1,3(4)-beta-glucanase | 0.002 | 0.0191 | 0.0077 |
Brugia malayi | PAN domain containing protein | 0.002 | 0.0191 | 0.0158 |
Loa Loa (eye worm) | hypothetical protein | 0.0428 | 1 | 1 |
Brugia malayi | PAN domain containing protein | 0.002 | 0.0191 | 0.0158 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0191 | 0.0191 |
Onchocerca volvulus | 0.0428 | 1 | 1 | |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0018 | 0.0135 | 0.037 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0035 | 0.0534 | 0.1468 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0191 | 0.0191 |
Toxoplasma gondii | PAN domain-containing protein | 0.002 | 0.0191 | 0.0077 |
Echinococcus multilocularis | lamin | 0.0026 | 0.0325 | 0.0892 |
Brugia malayi | PAN domain containing protein | 0.002 | 0.0191 | 0.0158 |
Toxoplasma gondii | microneme protein MIC17C | 0.002 | 0.0191 | 0.0077 |
Schistosoma mansoni | hypothetical protein | 0.0164 | 0.3639 | 1 |
Toxoplasma gondii | PAN domain-containing protein | 0.002 | 0.0191 | 0.0077 |
Toxoplasma gondii | microneme protein, putative | 0.002 | 0.0191 | 0.0077 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0534 | 0.114 |
Echinococcus multilocularis | Protein lozenge | 0.0054 | 0.099 | 0.272 |
Toxoplasma gondii | subtilisin SUB12 | 0.002 | 0.0191 | 0.0077 |
Loa Loa (eye worm) | hypothetical protein | 0.0428 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0325 | 0.0325 |
Onchocerca volvulus | 0.0026 | 0.0325 | 0.0136 | |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0026 | 0.0325 | 0.0292 |
Brugia malayi | PAN domain containing protein | 0.002 | 0.0191 | 0.0158 |
Echinococcus multilocularis | musashi | 0.0026 | 0.0325 | 0.0892 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0191 | 0.0191 |
Brugia malayi | PAN domain containing protein | 0.002 | 0.0191 | 0.0158 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0534 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0191 | 0.0191 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0018 | 0.0135 | 0.0135 |
Echinococcus granulosus | lamin dm0 | 0.0026 | 0.0325 | 0.0892 |
Toxoplasma gondii | microneme protein MIC17A | 0.002 | 0.0191 | 0.0077 |
Echinococcus multilocularis | lamin dm0 | 0.0026 | 0.0325 | 0.0892 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0191 | 0.0191 |
Schistosoma mansoni | intermediate filament proteins | 0.0026 | 0.0325 | 0.0542 |
Toxoplasma gondii | PAN domain-containing protein | 0.0318 | 0.7364 | 1 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0018 | 0.0135 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0313 | 0.0313 |
Toxoplasma gondii | PAN/Apple domain-containing protein | 0.002 | 0.0191 | 0.0077 |
Brugia malayi | intermediate filament protein | 0.0026 | 0.0325 | 0.0292 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0026 | 0.0325 | 0.0325 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0018 | 0.0135 | 0.5 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0018 | 0.0135 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0534 | 1 |
Loa Loa (eye worm) | PAN domain-containing protein | 0.002 | 0.0191 | 0.0191 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0018 | 0.0135 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0035 | 0.0534 | 0.1468 |
Brugia malayi | PAN domain containing protein | 0.002 | 0.0191 | 0.0158 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0018 | 0.0135 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0534 | 1 |
Toxoplasma gondii | microneme protein MIC17B | 0.002 | 0.0191 | 0.0077 |
Echinococcus granulosus | geminin | 0.0164 | 0.3639 | 1 |
Echinococcus multilocularis | geminin | 0.0164 | 0.3639 | 1 |
Toxoplasma gondii | PAN domain-containing protein | 0.002 | 0.0191 | 0.0077 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0018 | 0.0135 | 0.0102 |
Toxoplasma gondii | hypothetical protein | 0.002 | 0.0191 | 0.0077 |
Loa Loa (eye worm) | runx1 | 0.0054 | 0.099 | 0.099 |
Schistosoma mansoni | hypothetical protein | 0.005 | 0.09 | 0.2185 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0191 | 0.0191 |
Echinococcus granulosus | intermediate filament protein | 0.0026 | 0.0325 | 0.0892 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
RBA (binding) | < 0.01 % | Relative binding affinity (RBA) at Human estrogen receptor alpha (radiometric binding assay with [3H]-estradiol using full-length human ER alpha) | ChEMBL. | 11708925 |
RBA (binding) | < 0.01 % | Relative binding affinity (RBA) at Human estrogen receptor alpha (radiometric binding assay with [3H]-estradiol using full-length human ER alpha) | ChEMBL. | 11708925 |
RBA (binding) | = 0.043 % | Relative binding affinity (RBA) at human estrogen receptor beta (radiometric binding assay with [3H]-estradiol using full-length human ER Beta) | ChEMBL. | 11708925 |
RBA (binding) | = 0.043 % | Relative binding affinity (RBA) at human estrogen receptor beta (radiometric binding assay with [3H]-estradiol using full-length human ER Beta) | ChEMBL. | 11708925 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.